Tiago Milheiro Silva

发表

Saliva molecular testing bypassing RNA extraction is suitable for monitoring and diagnosing SARS-CoV-2 infection in children

Vasco M. Barreto, J. Demengeot, S. Vale-Costa, 2021, medRxiv.

Performance of QuantiFERON-TB Gold Plus assays in paediatric tuberculosis: a multicentre PTBNET study

R. Krüger, D. Buonsenso, M. Sali, 2022, Thorax.

Ketogenic Diet and Drug-Induced Hepatotoxicity During Tuberculosis Treatment

A. I. Dias, M. Brito, C. Gonçalves, 2022, JPGN Reports.

Severe mucositis without a rash induced by a Mycoplasma pneumoniae infection

M. Brito, Tiago Milheiro Silva, Ana Araújo Carvalho, 2021, BMJ Case Reports.

Protocol-based cardiotoxicity monitoring in hydroxychloroquine medicated COVID-19 pediatric patients

M. Brito, C. Gouveia, S. Laranjo, 2021, Revista Portuguesa de Cardiologia.

COVID‐19 infection triggered juvenile systemic lupus erythematosus‐like disease

M. Conde, C. Gouveia, Tiago Milheiro Silva, 2022, Journal of paediatrics and child health.

Immunological Reconstitution Inflammatory Syndrome and Thrombotic Microangiopathy: Severe Complications in a Child With Acquired Immunodeficiency Syndrome

Flora Candeias, C. Neves, Vera Brites, 2019, Clinical pediatrics.

Severe Stevens‐Johnson syndrome/toxic epidermal necrolysis overlap syndrome—beyond skin involvement

C. Gouveia, L. Varandas, João Farela Neves, 2018, Pediatric dermatology.

[Pediatric Tuberculosis: 12 Years of Experience in a Tertiary Referral Center in Portugal].

M. J. Brito, C. Gouveia, M. Borges, 2022, Acta medica portuguesa.